K231038

Substantially Equivalent

Global Hypoperfusion Index (GHI) Algorithm

Applicant: Edwards Lifesciences, LLC
Product code: QNL
Advisory panel: Cardiovascular
Date received: 2023-04-12
Decision date: 2023-07-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.